Cargando…
Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel
BACKGROUND: Interindividual variability of pharmacogenetics may account for unpredictable neurotoxicities of taxanes. METHODS: From March 2011 to June 2015, female patients with operable breast cancer who had received docetaxel- or paclitaxel-containing adjuvant chemotherapy were included in this st...
Autores principales: | Kus, Tulay, Aktas, Gokmen, Kalender, Mehmet Emin, Demiryurek, Abdullah Tuncay, Ulasli, Mustafa, Oztuzcu, Serdar, Sevinc, Alper, Kul, Seval, Camci, Celaletdin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990373/ https://www.ncbi.nlm.nih.gov/pubmed/27574448 http://dx.doi.org/10.2147/OTT.S106574 |
Ejemplares similares
-
Polymorphisms in the MTHFR gene are associated with recurrence risk in lymph node-positive breast cancer patients
por: Suner, Ali, et al.
Publicado: (2016) -
Prognostic impact of initial maximum standardized uptake value of (18)F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib
por: Kus, Tulay, et al.
Publicado: (2015) -
Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer patients: a single-center retrospective study
por: Aktas, Gokmen, et al.
Publicado: (2016) -
Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?
por: Kus, Tulay, et al.
Publicado: (2015) -
Collision tumor consisting of primary follicular lymphoma and adenocarcinoma in the cecum: A case report and literature review
por: KUS, TULAY, et al.
Publicado: (2016)